Diffuse Anaplastic Wilms Tumor in a Child With LAMA2 -related Muscular Dystrophy.

Area of Science:

• Genetics and rare diseases
• Pediatric oncology
• Neuromuscular disorders

Background:

• Laminin alpha-2-related muscular dystrophy (LAMA2-MD) is a rare autosomal recessive disorder caused by LAMA2 gene mutations.
• LAMA2-MD is not typically associated with an increased risk of cancer.
• Diffuse anaplastic Wilms tumor (DAWT) is a rare and aggressive form of pediatric kidney cancer.

Observation:

• A 4-year-old female presented with both LAMA2-MD and stage III DAWT.
• The patient's existing neuromuscular dysfunction and potential cardiomyopathy due to LAMA2-MD were critical considerations.

Findings:

• The patient's DAWT was managed with risk-adapted adjuvant chemotherapy.
• Chemotherapy was specifically modified by omitting vincristine and doxorubicin to prevent exacerbating the patient's LAMA2-MD symptoms.
• This approach highlights the successful management of a rare dual diagnosis.

Implications:

• This case demonstrates the possibility of sporadic co-occurrence of LAMA2-MD and DAWT.
• It underscores the importance of individualized treatment strategies in pediatric oncology for patients with complex comorbidities.
• Successful risk-adapted management provides a potential model for similar rare cases, balancing cancer treatment with the management of underlying genetic disorders.